Resmed Inc Drc Stock Earnings Per Share
| RMEA Stock | EUR 21.60 0.20 0.92% |
Resmed Inc DRC fundamentals help investors to digest information that contributes to Resmed's financial success or failures. It also enables traders to predict the movement of Resmed Stock. The fundamental analysis module provides a way to measure Resmed's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Resmed stock.
Resmed |
Resmed Inc DRC Company Earnings Per Share Analysis
Resmed's Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Current Resmed Earnings Per Share | 0.51 X |
Most of Resmed's fundamental indicators, such as Earnings Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Resmed Inc DRC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
| Competition |
According to the company disclosure, Resmed Inc DRC has an Earnings Per Share of 0.51 times. This is 93.91% lower than that of the Healthcare sector and 45.16% lower than that of the Medical Instruments & Supplies industry. The earnings per share for all Germany stocks is 83.65% higher than that of the company.
Resmed Earnings Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Resmed's direct or indirect competition against its Earnings Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Resmed could also be used in its relative valuation, which is a method of valuing Resmed by comparing valuation metrics of similar companies.Resmed is rated below average in earnings per share category among its peers.
Resmed Fundamentals
| Return On Equity | 0.24 | |||
| Return On Asset | 0.12 | |||
| Profit Margin | 0.22 % | |||
| Operating Margin | 0.28 % | |||
| Current Valuation | 31.38 B | |||
| Shares Outstanding | 1.47 B | |||
| Shares Owned By Institutions | 7.92 % | |||
| Price To Earning | 41.55 X | |||
| Price To Book | 9.35 X | |||
| Price To Sales | 8.00 X | |||
| Revenue | 3.58 B | |||
| Gross Profit | 2.06 B | |||
| EBITDA | 1.19 B | |||
| Net Income | 779.44 M | |||
| Cash And Equivalents | 147.13 M | |||
| Cash Per Share | 0.10 X | |||
| Total Debt | 765.33 M | |||
| Debt To Equity | 61.30 % | |||
| Current Ratio | 2.06 X | |||
| Book Value Per Share | 6.36 X | |||
| Cash Flow From Operations | 351.15 M | |||
| Earnings Per Share | 0.51 X | |||
| Price To Earnings To Growth | 1.73 X | |||
| Number Of Employees | 8.16 K | |||
| Beta | 0.47 | |||
| Market Capitalization | 29.64 B | |||
| Total Asset | 5.1 B | |||
| Z Score | 22.8 | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 5.1 B | |||
| Last Dividend Paid | 1.72 |
About Resmed Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Resmed Inc DRC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Resmed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Resmed Inc DRC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Resmed Stock
Resmed financial ratios help investors to determine whether Resmed Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Resmed with respect to the benefits of owning Resmed security.